[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?]
1Institut für Pathologie, Universitätsspital Zürich, Schmelzbergstr.12, 8091, Zürich, Schweiz. holger.moch@usz.ch.
Abstract:
The first S3 guidelines on renal cell cancer cover the practical aspects of imaging, diagnostics and therapy as well as the clinical relevance of pathology reporting. This review summarizes the changes in renal tumor classification and the new recommendations for reporting renal cell tumors. The S3 guidelines recommend the 2016 World Health Organization (WHO) classification of renal cell tumors. Novel renal cell tumor entities and provisional or emerging renal cell tumor entities of the 2016 WHO classification of renal tumors are discussed. The S3 guidelines for renal cell cancer also recommend the use of the WHO/International Society of Urologic Pathology (ISUP) grading system for clear cell and for papillary renal cell carcinomas, which replaces the previously used Fuhrman grading system.
More Related Videos
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury I: Introduction
Urinary Tract Calculi III: Medical Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...


